Your browser doesn't support javascript.
loading
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial.
Ferreira, João Pedro; Collier, Timothy; Clark, Andrew L; Mamas, Mamas A; Rocca, Hans-Peter Brunner-La; Heymans, Stephane; González, Arantxa; Ahmed, Fozia Z; Petutschnigg, Johannes; Mujaj, Blerim; Cuthbert, Joe; Rouet, Philippe; Pellicori, Pierpaolo; Mariottoni, Beatrice; Cosmi, Franco; Edelmann, Frank; Thijs, Lutgarde; Staessen, Jan A; Hazebroek, Mark; Verdonschot, Job; Rossignol, Patrick; Girerd, Nicolas; Cleland, John G; Zannad, Faiez.
Afiliação
  • Ferreira JP; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, 4 rue du Morvan, 54500 Nancy, France.
  • Collier T; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Clark AL; Department of Academic Cardiology, University of Hull, Daisy Building, Castle Hill Hospital, Castle Road, Cottingham, UK.
  • Mamas MA; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester & Keele Cardiovascular Research Group, Keele University, Keele, UK.
  • Rocca HB; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Heymans S; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • González A; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain.
  • Ahmed FZ; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester & Keele Cardiovascular Research Group, Keele University, Keele, UK.
  • Petutschnigg J; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, and German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Germany.
  • Mujaj B; Department of Diagnostic and Interventional Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Cuthbert J; Department of Academic Cardiology, University of Hull, Daisy Building, Castle Hill Hospital, Castle Road, Cottingham, UK.
  • Rouet P; Institut de Médecine Moléculaire de Rangueil, UMR INSERM, Toulouse 1048, France.
  • Pellicori P; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
  • Mariottoni B; Department of Cardiology, Cortona Hospital, Arezzo, Italy.
  • Cosmi F; Department of Cardiology, Cortona Hospital, Arezzo, Italy.
  • Edelmann F; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, and German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Germany.
  • Thijs L; Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Staessen JA; Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Hazebroek M; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Verdonschot J; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Rossignol P; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, 4 rue du Morvan, 54500 Nancy, France.
  • Girerd N; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, 4 rue du Morvan, 54500 Nancy, France.
  • Cleland JG; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
  • Zannad F; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, 4 rue du Morvan, 54500 Nancy, France.
Eur Heart J Cardiovasc Pharmacother ; 8(2): 149-156, 2022 02 16.
Article em En | MEDLINE | ID: mdl-33822033
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espironolactona / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espironolactona / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article